Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Aeterna Zentaris Inc T.AEZS

Alternate Symbol(s):  AEZS

Healthcare Biotechnology
Aeterna Zentaris Inc. is a Canada-based specialty biopharmaceutical company. The Company is developing and commercializing a diversified portfolio of pharmaceutical and diagnostic products focused on areas of significant unmet medical need. The Company's lead product, macimorelin (Macrilen, Ghryvelin), is an oral test indicated for the diagnosis of adult growth hormone deficiency (AGHD). The... see more

Recent & Breaking News (TSX:AEZS)

Ceapro Receives Final Court Approval for Merger with Aeterna Zentaris

GlobeNewswire March 28, 2024

Aeterna Zentaris Reports Fourth Quarter and Full Year 2023 Financial Results and Announces Completion of Enrollment in Ongoing Pivotal DETECT-Trial for the Diagnosis of Childhood-Onset Growth Hormone Deficiency

GlobeNewswire March 27, 2024

Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings

GlobeNewswire March 12, 2024

Leading Independent Proxy Advisory Firm ISS Recommends Aeterna Zentaris and Ceapro Securityholders Vote FOR the Arrangement Agreement to Approve the Merger of Equals to Create a Diversified Biopharmaceutical Company

GlobeNewswire February 26, 2024

Aeterna Zentaris Issues Letter to Shareholders and Management Proxy Circular Ahead of Special Meeting of Shareholders to Approve Merger of Equals with Ceapro

GlobeNewswire February 15, 2024

SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CVLY, EVFM, AEZS, HOLI

PR Newswire December 19, 2023

SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Aeterna Zentaris Inc. Merger

Newsfile December 18, 2023

Lifshitz Law PLLC Announces Investigations of ORRF, RAIN, BLBX, and AEZS

Accesswire December 15, 2023

AEZS Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of Aeterna Zentaris Inc. Is Fair to Shareholders

Business Wire December 14, 2023

Canadian Investment Regulatory Organization Trade Resumption - AEZS

Canada NewsWire December 14, 2023

Canadian Investment Regulatory Organization Trading Halt - AEZS

Canada NewsWire December 14, 2023

Aeterna Zentaris and Ceapro Announce Merger of Equals to Create a Diversified Biopharmaceutical Company

GlobeNewswire December 14, 2023

Aeterna Zentaris Reports Third Quarter 2023 Financial Results

GlobeNewswire November 9, 2023

Aeterna Zentaris to Participate at the Virtual Investor Ask the CEO Conference

GlobeNewswire October 11, 2023

Aeterna Zentaris to Present at the H.C. Wainwright 25th Annual Global Investment Conference

GlobeNewswire September 5, 2023

Aeterna Zentaris Reports Second Quarter 2023 Financial Results

GlobeNewswire August 9, 2023

Aeterna Zentaris Outlines Progress on Development Pipeline Programs and Provides Corporate Update

GlobeNewswire July 13, 2023

Aeterna Zentaris to Participate in the Virtual Investor Summer Spotlight Series

GlobeNewswire July 5, 2023

Aeterna Zentaris Announces Results of Virtual 2023 Meeting of Shareholders

GlobeNewswire June 14, 2023

Aeterna Zentaris Announces Virtual 2023 Meeting of Shareholders

GlobeNewswire May 15, 2023